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bypass graft postoperative surgical site infection
accurately from claims data?
Tsung-Hsien Yu1,2, Yu-Chang Hou1,3,4, Kuan-Chia Lin5 and Kuo-Piao Chung1,2*Abstract
Background: Claims data has usually been used in recent studies to identify cases of healthcare-associated
infection. However, several studies have indicated that the ICD-9-CM codes might be inappropriate for identifying
such cases from claims data; therefore, several researchers developed alternative identification models to correctly
identify more cases from claims data. The purpose of this study was to investigate three common approaches to
develop alternative models for the identification of cases of coronary artery bypass graft (CABG) surgical site
infection, and to compare the performance between these models and the ICD-9-CM model.
Methods: The 2005–2008 National Health Insurance claims data and healthcare-associated infection surveillance
data from two medical centers were used in this study for model development and model verification. In addition
to the use of ICD-9-CM codes, this study also used classification algorithms, a multivariable regression model, and a
decision tree model in the development of alternative identification models. In the classification algorithms, we
defined three levels (strict, moderate, and loose) of the criteria in terms of their strictness. Sensitivity, specificity,
positive predictive value, negative predictive value, and accuracy were used to evaluate the performance of each
model.
Results: The ICD-9-CM-based model showed good specificity and negative predictive value, but sensitivity and
positive predictive value were poor. Performances of the other models were varied, except for negative predictive
value. Among the models, the performance of the decision tree model was excellent, especially in terms of
positive predictive value.
Conclusion: The accuracy of identification of cases of CABG surgical site infection is an important issue in claims
data. Use of the decision tree model to identify such cases can improve the accuracy of patient-level outcome
research. This model should be considered when performing future research using claims data.
Keywords: Administrative data, Identification model, CABG, Surgical site infection, Decision tree, Classification and
regression treeBackground
Healthcare-associated infection has become an important
issue in the past decades, and large studies have been
implemented using claims data [1-3]. In contrast to sur-
veillance data, the use of administrative data can increase
sample sizes due to reduced labor intensity, and it makes* Correspondence: kpchung@ntu.edu.tw
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unless otherwise stated.multi-institutional studies easier to implement [4]. The
use of claims data can also facilitate the efficiency and
standardization of case identifications [1].
Researchers have identified cases of infection in claims
data through use of the International Classification of
Diseases, 9th Revision, Clinical Modification (hereafter
referred to as ICD-9-CM-based model). However, sev-
eral studies have indicated that this model might be inap-
propriate for identifying such cases in claims data [5-8],
primarily due to insufficient code lists or distortion by the
payment scheme and other factors [1,7,9,10], and theseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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cially in patient-level studies [6,11]. The use of surrogate
markers or development of identification models has been
popular in the identification of cases of healthcare-associ-
ated infection since 2000. Current studies usually adopted
one of the below three approaches. The first approach
is the classification algorithms, in which unweighted
algorithm with consecutive dichotomous decision steps is
used to enable screening of high-risk patients based on
limited number of electronic data sources [12]. Resear-
chers first define several criteria, and if a case satisfies
(or exceeds) a specific number of criteria (such as anti-
biotics utilization), then it will be identified as a case of
infection. For example, Lee et al. defined four criteria for
identifying cases of infection in gastrectomy patients, and
if any criterion was met, a case of infection was identified
[4]. The second approach is the multivariable regression
model. After manual review of high-risk patients, this
model incorporates electronic data sources into a weighted
regression or prediction model to divide patients into low-
and high-risk groups [12]. Researchers usually calculate a
risk score based on microbiology indicators of each case
and identify cases of infection by an optimal cut-off point.
For example, Fujii et al. used blood culture and medical
use indicators to calculate a risk score by the logistic
regression model, and the optimal cutoff point was de-
termined according to the resulting receiver operating
characteristic (ROC) curve [13].
The third is the data mining approach (e.g. decision
tree/classification and regression tree, artificial neural
network, etc.), which is widely used for predicting and
classifying objects, especially in the fields of information
technology, operational research, and advanced biosta-
tistics. The characteristics of data mining approach are:
automatic discovery of patterns, prediction of likely out-
comes, creation of actionable information, and focus on
large data sets and databases. However, it is rarely used
in the field of healthcare-associated infection [14,15]. Re-
gardless of the approach used, the sensitivity, specificity,
positive predictive value and negative predictive value
were usually adopted to evaluate the performance of the
model, and it is found that alternative identification ap-
proaches all had model performance better than that with
the ICD-9-CM-based model.
Although research quality can be improved by improv-
ing the accuracy of identification of infection cases, there
is no study, to our knowledge, that has compared these
three approaches, and no study has differentiated which
approach is the best. In addition, the best approach for the
Taiwan National Health Insurance Database is unknown.
Therefore, the purpose of this study was to use these
approaches to develop alternative models for identifying
cases of coronary artery bypass grafting (CABG) surgical
site infection; all approaches (ICD-9-CM-based model andthe alternative approaches) will be compared to surveil-
lance by infection control personnel, and then the perfor-
mance of the ICD-9-CM-based model will be compared
to the other methods. Furthermore, model verification
was also implemented in this study.
Methods
This retrospective study used data from coronary artery
disease patients admitted to two medical centers in Taiwan
for CABG surgery. The performance of the ICD-9-CM-
based model and five alternative models was compared in
this study.
Data sources
The 2005–2008 National Health Insurance claims data
and healthcare-associated infection surveillance data from
two medical centers were used in this study. There were
1,017 CABG surgeries performed at medical center A and
845 performed at medical center B, with 24 surgical site
infections (SSIs) occurring at medical center A and 17
occurring at medical center B.
The dataset from medical center A was used for data
training (model development), and the dataset from
medical center B was used for model verification. The
National Health Insurance claims data is a de-identified
secondary database containing patient-level demographic
and administrative information. Treatment items were ag-
gregated and were without time-related information. For
example, if a patient received 1 ml cefazolin before sur-
gery, and another 1 ml during surgery, and then 1 ml after
surgery, it will be presented as 3 ml of cefazolin during
the hospitalization.
Ethical statement
The protocol for this study was approved by the Institu-
tional Review Board of the National Taiwan University
Hospital (protocol #201001027R). The dataset we used in
this study was the secondary data, all information was de-
identified by data owners. Inform consent was not neces-
sary in current study.
The protocol for this study was approved by the Insti-
tutional Review Board of the National Taiwan University
Hospital (protocol #201001027R).
Exclusion criteria
Patients were excluded from analysis if they were: (1)
aged <20 years, (2) had postoperative surgical site infec-
tion due to prior operation, and (3) mortality after surgery
in hospital.
SSI case identification based on ICD-9-CM
(ICD-9-CM-based model)
SSI case identification based on the ICD-9-CM was di-
vided into two categories: index hospitalization events and
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discharge and require readmission to a hospital and/or the
use of ambulatory services). The ICD-9-CM codes for
hospitalization events are 996.03, 996.61, 996.72, and 998.5.
The ICD-9-CM codes for ambulatory services events are
038.0-038.4, 038.8, 038.9, 682.6, 682.9, 780.6, 790.7, 875.0,
875.1, 891.0, 891.1, 996.03, 996.61, 996.72, 998.3, and 998.5.
Following Wu et al., this study adopted the secondary
ICD-9-CM diagnosis codes for index hospitalization
events, and the primary and secondary diagnosis
codes for post-discharge events as criteria for SSI to
avoid cases in which infection developed prior to
hospitalization [16].
SSI case identification based on surrogate indicators
After referring to the literature [1,17] and conferring with
infectious disease specialists, we determined the criteria
used by the alternative models to be the following: type of
antibiotics, doses of antibiotics, doses of cefazolin, use of
second-line antibiotics (see Table 1), length of hospital
stay, and number of vessels obstructed.
In models 1 to model 3, we adopted classification algo-
rithms to develop an identification model. All criteria were
converted into binary format. The criteria were (1) use of
more than three types of antibiotics, (2) use of more than
seven defined daily doses (DDD) of antibiotics, (3) use of
more than 7DDD of cefazolin, (4) use of second-line anti-
biotics, (5) length of stay > 21 days, and (6) number of
vessels obstructed > 2 (as a proxy indicator of duration of
operation [18]). Although existing studies provided a sug-
gestion base of criterion selection, such criteria varied
across countries. For example, most surgeons in Taiwan
prescribe 3 to 7 days of prophylactic antibiotic for CABG
surgery, which is longer than the usual practice in western
countries. Therefore, all criteria were further discussed
with local surgeons. We defined a strict standard in
model 1: the patient was identified as an SSI case only if
all criteria were satisfied. The standard for model 2 was
moderate: the patient was identified as an SSI case if more
than three criteria were satisfied. The standard for model
3 was loose: the patient was identified as an SSI case if any
of the criteria were satisfied.
We conducted a multivariable regression model in
model 4 and used logistic regression to calculate the risk
probability of cases with the same criteria we used in the
classification algorithms. Different from models 1, 2, and
3, all binary variables were converted into continuous
variables. The stepwise variable selection procedure was
performed to avoid multicollinearity. We identified the
optimal cut-off value from the ROC curves. The best
cut-off value that corresponds to this perfect scenario
(100% sensitivity and 100% specificity) would be at the
upper left corner. In practice however, fewer tests are
perfect, and one has to strike a balance between sensitivityand specificity. The Youden index was used to determine
the optimal cut-off point [19].
The decision tree model was applied in model 5. This
model is also known as the classification and regression
tree (CART) model. Growing, stopping, and pruning of
the tree were determined by Gini improvement measures
[20,21]. We also adopted cross-validation to verify
the final model. The model-building set was then
used to establish a tree that was pruned by use of
the validation set to achieve an estimation of the most
appropriate tree through minimal cost-complexity
pruning [20,21]. The criteria were the same as those
for model 4.
Model development, verification, and analysis of
performance
The claims and surveillance data from medical center A
were used to develop the alternative identification models
with the use of IBM PASW 18 software, and the data
from medical center B were used for verification. The
healthcare-associated infection surveillance data were used
as the reference standard.
Infection cases based on surveillance were identified
by infection control personnel if the patient met the
Taiwan CDC’s criterions, which are the same as that of
the U.S. CDC. They manually review medical records of
all patients at risk for the specified healthcare-associated
infection.
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then analyzed using sensitivity (number of infected pa-
tients with positive test/total number of infected patients),
specificity (number of non-infected patients with negative
test/total number of non-infected patients), positive pre-
dictive value (number of infected patients with positive
test/total number of patients with positive test), negative
predictive value (number of non-infected patients with
negative test/total number of patients with negative test),
and accuracy (number of infected patients with positive
test + number of non-infected patients with negative test/
total number of patients).
Results
During the period 2005 to 2008, 1,017 patients under-
went CABG surgery in medical center A (see Table 2),
and 24 of them were confirmed as SSI cases by infection
control professionals. The majority of patients were men
(78.2%), and the mean age of the patients was 65 years.
The mean level of number of vessels obstructed and
length of stay were 1.88 and 18.09 days respectively. The
mean number of types and doses of antibiotics were 1.57
and 8.27 respectively. Cefazolin was administered to 998
(97.15%) patients during the period of inpatient stay,
and the mean number of doses was 3.93DDD. Second-
line antibiotics were administered to 115 (11.58%) pa-
tients. The results also revealed that 45 cases of CABG
SSI were identified by the ICD-9-CM approach, which
represented an overestimation of the SSI rate among
CABG cases in this medical center by the ICD-9-CM
approach. The data also showed statistically signifi-
cant differences between SSI cases and non-SSI cases
for all variables except for age.
Table 3 demonstrates the results of stepwise selection




Age (years)† 65.03 (10.86)
Number of vessels obstructed† 1.88 (0.34)
Length of stay (days)† 18.09 (12.64)
Length of stay (days)* 16 (8)
Type of antibiotics† 1.57 (1.00)
Doses of antibiotics† 8.27 (9.05)
Use of cefazolin‡ 998 (97.15)
Doses of cefazolin† 3.93 (2.18)
ICD-9-CM SSI code‡ 45 (4.4%)
Use of second-line antibiotics‡ 115 (11.58)
CABG: coronary artery bypass graft; SSI: surgical site infection.
†Mean(S.D) ‡N(%) *Median(IQR).length of stay and type of antibiotics were retained in
the model. The value of area under ROC curve was
0.989 (95% confidence interval: 0.983-0.996). According
to the Youden index, the optimal cut-off value was 0.03.
The value of area under ROC curve in the verification
model was 0.978 (95% confidence interval: 0.961-0.994)
Figure 1 is an illustration of the decision tree for iden-
tifying CABG surgical site infection, in which the most
appropriate tree level is divided into seven terminal
nodes. After model development by PASW 18, length of
stay, type of antibiotics, dose of cefazolin, and number of
vessels obstructed were retained in the model. Terminal
node 3 indicates that when the length of stay is less than
45.5 days and the type of antibiotics is six, 80% of
patients were identified as surgical site infection cases.
The other combinatorial paths, interrelationships, pre-
dicted probabilities and populations are also illustrated
in Figure 1. The tree diagram after pruning is presented
in Figure 2.
Table 4 shows the performance of the training data
(medical center A). The ICD-9-CM-based model had
good specificity and negative predictive value, but its
sensitivity and positive predictive value were poor. We
found that performance varied in the other models
except for negative predictive value. The performance
of model 5 (without pruning) was excellent compared
with that of the other models, especially in terms of
positive predictive value. The performance of pruning
model was the same with that of without pruning
model.
We used the data of medical center B for model verifi-
cation (Table 5). The performance of the verification
models was quite similar to that of the training data.
The ICD-9-CM-based model showed good specificity
and negative predictive value, but the sensitivity andedical center A during 2005-2008
Non-SSI SSI P-value
993 (97.64) 24 (2.36)
781 (78.65) 14 (58.33) 0.017
64.98 (10.86) 67.14 (10.95) 0.949
1.89 (0.33) 1.67 (0.56) <0.001
17.11 (6.60) 58.29 (58.72) <0.001
16 (7) 47.5 (21.5)
1.51 (0.90) 3.71 (2.10) <0.001
7.89 (8.43) 24.07 (16.84) <0.001
975 (98.19) 13 (54.17) <0.001
3.96 (2.12) 2.65 (3.61) <0.001
36 (3.63) 9 (37.50) <0.001
115 (11.58) 20 (83.33) <0.001
Table 3 The results of stepwise selection of model
4-logistic regression model (training data)
Parameter Estimate Standard error p-value
Intercept 10.0204 1.1212 <.0001
Length of stay −0.1581 0.0233 <.0001
Type of antibiotics −0.7427 0.1939 0.0001
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the performance of the other models to vary except
for negative predictive value. As with the training
data, the performance of model 5 was excellent com-
pared with the other models, especially for positive
predictive value.
Discussion
The purpose of this study was to adopt three approaches
to develop alternative models based on surrogate indica-
tors to identify cases of CABG surgical site infection and
to compare the performance among these models and
the ICD-9-CM-based model. The main finding of this
study was that the decision tree model we developed
(model 5) offered better performance than that of the
other identification models or the ICD-9-CM-based model,
especially with regard to positive predictive value. The
decision tree model was a decidedly better tool for identi-
fying cases of SSI in the Taiwan National Health Insurance
database. Furthermore, the results of this study could pro-
vide healthcare authorities with a tool to monitor surgical
site infection among CABG patients, and can serve as a
base for future research.
In Taiwan, surgeons prescribe antibiotics pre-, during
and post-operation for preventing surgical site infection,
and cefazolin is the most common one for prophylaxis
use in CABG. However, there was no compulsory regu-
lation on prescription, and surgeons can freely decide
the type and dosage of antibiotics. Nevertheless, most sur-
geons usually prescribe first-line antibiotics (e.g. cefazolin)
as prophylactic antibiotic.
This study highlighted three issues that are worthy of
discussion. First, could surrogate markers be better than
ICD-9-CM codes to identify cases of SSI in claims data?
Researchers usually identified such cases through ICD-
9-CM codes in claims data; however, many researchers
have stated that use of ICD-9-CM codes to identify
infection cases might be problematic [9,22,23]. In this
study, infection rate calculated using ICD-9 CM codes
was overestimated by factors of 2 and 2.2 respectively, in
comparison with the actual rates in medical centers A
and B. Previous studies adopted medical use as the sur-
rogate marker for identifying cases of infection in claims
data [1,4,24-27], and found better performance than that
with the ICD-9-CM-based model. For example, Lee and
colleagues [4] developed an alternative model based onantibiotic use to identify healthcare-associated infections
in gastrectomy cases in Japan. Unlike their study that could
differentiate the use of antibiotics between treatment
and prophylaxis purposes, items recorded in the Taiwan
National Health Insurance database are aggregated and
were without time-relevant information. The present
study could not identify the sequence of treatment, nor
could it distinguish the purpose of use of antibiotics.
Furthermore, the current study was inspired by Lee et al.,
hence we selected “more than three types of antibiotics
and use of second-line antibiotics” as the criterion. The
results that the performance of all models except for model
2 were better than or equal to that of the ICD-9-CM-based
model implied that medical use could be a surrogate
for ICD-9-CM codes in claims data.
Second, positive predictive value should be the criter-
ion to determine the identification model. Most studies
used sensitivity and specificity as indicators to evaluate
the performance. The results of other studies [1,4,17]
which used positive predictive value to evaluate the
performance showed that the performance of positive
predictive value was not good because of the lack of
infection events [5,28]. For example, in Lee et al., study
[4], sensitivity, specificity, and negative predictive values
were over 90%, but the positive predictive value was
around 70%.Similar with previous studies, current study
found that the positive predictive value was lower than
the other indicators, except for model 1. Besides, the
positive predictive value of model 5 was significantly
better than the others.
Third, the decision tree model should be the recom-
mended approach. In general, classification algorithms
were intuitional and this method was easy to perform.
However, determination of the optimal criteria and def-
inition of the cutoff point for each criterion (e.g., length
of stay >7 days) were challenges to work out. Although a
multivariable regression model can consider all variables
simultaneously, which can also deal with continuous var-
iables, it has limitations in dealing with high-dimension
variables [21,29]. And the performances of the decision
tree model were better than others, which can be attrib-
uted to the ability of the decision tree model to classify
high-dimensional data [29]. The decision tree model is a
computer-aided decision-making approach that can help
researchers figure out the optimal solution to find cases
that they are concerned about. However, it is not widely
used in academic medical societies, and most colleagues
in medical societies might not be familiar with this ap-
proach. As shown in the results, the performances were
similar between Model 4 and Model 5, except for the
positive predictive value. Furthermore, the current study
found that while the sensitivity of model 4 was equal
to model 5 (87.5%), the specificity, positive predictive
value, negative predictive value and accuracy were
Figure 1 Decision tree model for identifying cases of CABG surgical site infection. SSI: surgical site infection; los: length of stay; Anti: type
of antibiotics; CEFA_DDD:dosage of cefazolin; vessels_obstructed: number of vessels obstructed.
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Figure 2 Decision tree model for identifying cases of CABG surgical site infection (after pruning). SSI: surgical site infection; los: length of
stay; Anti: type of antibiotics; CEFA_DDD:dosage of cefazolin.
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Table 4 Performance of the ICD-9-CM-based and alternative models for identifying CABG SSIs (training data: medical
center A)
Sensitivity Specificity PPV NPV Accuracy
ICD-9-CM-based model 37.50% (9/24) 96.27% (956/993) 19.57% (9/46) 98.46% (956/971) 94.89% (965/1017)
Model 1 4.17% (1/24) 99.90% (992/993) 50.00% (1/2) 97.73% (992/1015) 97.64% (993/1017)
Model 2 54.17% (13/24) 96.78% (961/993) 28.89% (13/45) 98.87% (961/972) 95.77% (974/1017)
Model 3 100.00% (24/24) 3.22% (32/993) 2.44% (24/985) 100.00% (32/32) 5.51% (56/1017)
Model 4 100.00% (24/24) 94.56 (939/993) 30.77% (24/78) 100.00% (939/939) 94.69% (963/1017)
Model 5 87.50% (21/24) 99.40% (987/993) 77.78% (21/27) 99.70% (987/990) 99.12% (1008/1017)
% (numerator/denominator).
ICD-9-CM: The International Classification of Diseases, Ninth Revision, Clinical Modification; PPV: positive predictive value; NPV: negative predictive value. Model 1:
the classification algorithms (strict); Model 2: the classification algorithms (moderate); Model 3: the classification algorithms (loose); Model 4: the multivariable
regression model: Model 5: data mining-decision tree model.
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and 97.5% (992/1017) respectively. The results gained
demonstrated the better performance of model 5 over
model 4.
This study has several limitations. Firstly, there is
room for improvement of the positive predictive value
(>75%) of Model 5, and its performance was not worse
than that reported in existing studies [1,4,17]. However,
we could not distinguish between therapeutic and prophy-
lactic use of antibiotics because of a limitation of the data-
set. If we could obtain such information, it might be
useful in improving performance. Secondly, we used six
criteria, and we could only select loose, moderate, and
strict combinations of these criteria to develop identi-
fication models that represent the performance of all
possible combinations. Thirdly, study generalizability,
identification model development, and model verifica-
tion were limited by the use of the National Health
Insurance claims data and surveillance data from two
medical centers. Theoretically, the findings of this study
could be applied to other levels of hospitals in Taiwan as
well as other countries and payment systems. The major
reason is the methodological strength of the decision
tree model. Nevertheless, this merits further examination,
as we do not have data from different hospital levels andTable 5 Performance of model verification for identifying CAB
Sensitivity Specificity
ICD-9-CM-based model 35.29 (6/17) 96.98 (803/828)
Model 1 5.88 (1/17) 99.76 (826/828)
Model 2 52.94 (9/17) 97.46 (807/828)
Model 3 100.00 (17/17) 2.42 (20/828)
Model 4 94.12 (16/17) 94.93 (786/828)
Model 5 88.24 (15/17) 99.28 (822/828)
% (numerator/denominator).
ICD-9-CM: The International Classification of Diseases, Ninth Revision, Clinical Modif
the classification algorithms (strict); Model 2: the classification algorithms (moderate
regression model: Model 5: data mining-decision tree model.different countries. Fourthly, the reference standard in the
current study was the healthcare-associated infection
surveillance data.Infection cases were manually identi-
fied by infection control professionals, and Taiwan
CDC provided training and explicit criteria. However,
in some special cases, inconsistencies might exist
among hospitals, although such a situation was rare
[1]. Furthermore, some healthcare-associated infection
cases occurred after discharge. If patients did not return
to the same hospital, they would not be identified as
healthcare-associated infection cases in the surveillance
data [12].
Conclusion
In summary, use of ICD-9-CM codes with National
Health Insurance claims data in Taiwan to identify cases
of CABG SSI might overestimate the number of cases by
a factor of two. However, the accuracy of the decision
tree model, with medical uses as its parameters, was bet-
ter than that of the ICD-9-CM-based model, especially
in the sensitivity and positive predictive value. Use of the
decision tree model to identify cases of CABG surgical
site infection can improve the accuracy of patient-level
outcome research. This model should be considered in
future research using claims data.G SSIs (verification data: medical center B)
PPV NPV Accuracy
19.35 (6/31) 98.65 (803/814) 95.74 (809/845)
33.33 (1/3) 98.10 (826/842) 97.87 (827/845)
30.00 (9/30) 99.02 (807/815) 96.57 (816/845)
2.06 (17/825) 100.00 (20/20) 4.38 (37/845)
27.59 (16/58) 99.87 (786/787) 94.91 (802/845)
71.43 (15/21) 99.76 (822/824) 99.05 (838/845)
ication; PPV: positive predictive value; NPV: negative predictive value. Model 1:
); Model 3: the classification algorithms (loose); Model 4: the multivariable
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